Exact Mass: 433.2471
Exact Mass Matches: 433.2471
Found 500 metabolites which its exact mass value is equals to given mass value 433.2471
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Paspalinine
Hericenone B
Hericenone B is found in mushrooms. Hericenone B is isolated from the edible lions mane mushroom (Hericium erinaceum). Isolated from the edible lions mane mushroom (Hericium erinaceum). Hericenone B is found in mushrooms.
N-Eicosapentaenoyl Methionine
N-eicosapentaenoyl methionine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is an Eicosapentaenoic acid amide of Methionine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Eicosapentaenoyl Methionine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Eicosapentaenoyl Methionine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.
Ulipristal
Ilicicolin H
An aromatic ketone in which the ketone carbonyl group is attached to a (1R,2R,4aS,7S,8aR)-4,7-dimethyl-1-[(1E)-prop-1-en-1-yl]-1,2,4a,5,6,7,8,8a-octahydronaphthalen-2-yl group and a 4-hydroxy-5-(4-hydroxyphenyl)-2-oxo-1,2-dihydropyridin-3-yl group. Isolated from the from the "imperfect" fungus Cylindrocladium iliciola strain MFC-870.
(3S,8aS)-3-((7,7-dimethyl-2-(2-methylbut-3-en-2-yl)-1,7-dihydropyrano[2,3-g]indol-3-yl)methyl)-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione|notoamide E
Ser Val Thr Lys
C26H31N3O3_Pyrrolo[1,2-a]pyrazine-1,4-dione, 3-[[7-(1,1-dimethyl-2-propen-1-yl)-2,8-dihydro-2,2-dimethylpyrano[3,2-f]indol-6-yl]methyl]hexahydro
Notoamide E
A pyranoindole that is notoamide S in which the phenolic hydrosy group at position 6 of the indole moiety has formal addition to the 3-methylbut-2-en-1-yl group at postion 7 of the indole moiety to give the corresponding 7,7-dimethyl-1,7-dihydropyrano[2,3-g]indole derivative. Isolated from a mussel-derived Aspergillus species.
Ala Cys Ile Lys
Ala Cys Lys Ile
Ala Cys Lys Leu
Ala Cys Leu Lys
Ala Asp Lys Thr
Ala Asp Thr Lys
Ala Glu Lys Ser
Ala Glu Ser Lys
Ala Ile Cys Lys
Ala Ile Lys Cys
Ala Lys Cys Ile
Ala Lys Cys Leu
Ala Lys Asp Thr
Ala Lys Glu Ser
Ala Lys Ile Cys
Ala Lys Leu Cys
Ala Lys Ser Glu
Ala Lys Thr Asp
Ala Leu Cys Lys
Ala Leu Lys Cys
Ala Arg Ser Thr
Ala Arg Thr Ser
Ala Ser Glu Lys
Ala Ser Lys Glu
Ala Ser Arg Thr
Ala Ser Thr Arg
Ala Thr Asp Lys
Ala Thr Lys Asp
Ala Thr Arg Ser
Ala Thr Ser Arg
Cys Ala Ile Lys
Cys Ala Lys Ile
Cys Ala Lys Leu
Cys Ala Leu Lys
Cys Ile Ala Lys
Cys Ile Lys Ala
Cys Lys Ala Ile
Cys Lys Ala Leu
Cys Lys Ile Ala
Cys Lys Leu Ala
Cys Leu Ala Lys
Cys Leu Lys Ala
Asp Ala Lys Thr
Asp Ala Thr Lys
Asp Lys Ala Thr
Asp Lys Thr Ala
Asp Thr Ala Lys
Asp Thr Lys Ala
Glu Ala Lys Ser
Glu Ala Ser Lys
Glu Gly Lys Thr
Glu Gly Thr Lys
Glu Lys Ala Ser
Glu Lys Gly Thr
Glu Lys Ser Ala
Glu Lys Thr Gly
Glu Ser Ala Lys
Glu Ser Lys Ala
Glu Thr Gly Lys
Glu Thr Lys Gly
Gly Glu Lys Thr
Gly Glu Thr Lys
Gly Lys Glu Thr
Gly Lys Met Val
Gly Lys Thr Glu
Gly Lys Val Met
Gly Met Lys Val
Gly Met Val Lys
Gly Arg Thr Thr
Gly Thr Glu Lys
Gly Thr Lys Glu
Gly Thr Arg Thr
Gly Thr Thr Arg
Gly Val Lys Met
Gly Val Met Lys
Ile Ala Cys Lys
Ile Ala Lys Cys
Ile Cys Ala Lys
Ile Cys Lys Ala
Ile Lys Ala Cys
Ile Lys Cys Ala
Ile Lys Ser Ser
Ile Asn Ser Thr
Ile Asn Thr Ser
Ile Gln Ser Ser
Ile Ser Lys Ser
Ile Ser Asn Thr
Ile Ser Gln Ser
Ile Ser Ser Lys
Ile Ser Ser Gln
Ile Ser Thr Asn
Ile Thr Asn Ser
Ile Thr Ser Asn
Lys Ala Cys Ile
Lys Ala Cys Leu
Lys Ala Asp Thr
Lys Ala Glu Ser
Lys Ala Ile Cys
Lys Ala Leu Cys
Lys Ala Ser Glu
Lys Ala Thr Asp
Lys Cys Ala Ile
Lys Cys Ala Leu
Lys Cys Ile Ala
Lys Cys Leu Ala
Lys Asp Ala Thr
Lys Asp Thr Ala
Lys Glu Ala Ser
Lys Glu Gly Thr
Lys Glu Ser Ala
Lys Glu Thr Gly
Lys Gly Glu Thr
Lys Gly Met Val
Lys Gly Thr Glu
Lys Gly Val Met
Lys Ile Ala Cys
Lys Ile Cys Ala
Lys Ile Ser Ser
Lys Leu Ala Cys
Lys Leu Cys Ala
Lys Leu Ser Ser
Lys Met Gly Val
Lys Met Val Gly
Lys Ser Ala Glu
Lys Ser Glu Ala
Lys Ser Ile Ser
Lys Ser Leu Ser
Lys Ser Ser Ile
Lys Ser Ser Leu
Lys Ser Thr Val
Lys Ser Val Thr
Lys Thr Ala Asp
Lys Thr Asp Ala
Lys Thr Glu Gly
Lys Thr Gly Glu
Lys Thr Ser Val
Lys Thr Val Ser
Lys Val Gly Met
Lys Val Met Gly
Lys Val Ser Thr
Lys Val Thr Ser
Leu Ala Cys Lys
Leu Ala Lys Cys
Leu Cys Ala Lys
Leu Cys Lys Ala
Leu Lys Ala Cys
Leu Lys Cys Ala
Leu Lys Ser Ser
Leu Asn Ser Thr
Leu Asn Thr Ser
Leu Gln Ser Ser
Leu Ser Lys Ser
Leu Ser Asn Thr
Leu Ser Gln Ser
Leu Ser Ser Lys
Leu Ser Ser Gln
Leu Ser Thr Asn
Leu Thr Asn Ser
Leu Thr Ser Asn
Met Gly Lys Val
Met Gly Val Lys
Met Lys Gly Val
Met Lys Val Gly
Met Val Gly Lys
Met Val Lys Gly
Asn Ile Ser Thr
Asn Ile Thr Ser
Asn Leu Ser Thr
Asn Leu Thr Ser
Asn Ser Ile Thr
Asn Ser Leu Thr
Asn Ser Thr Ile
Asn Ser Thr Leu
Asn Thr Ile Ser
Asn Thr Leu Ser
Asn Thr Ser Ile
Asn Thr Ser Leu
Asn Thr Thr Val
Asn Thr Val Thr
Asn Val Thr Thr
Gln Ile Ser Ser
Gln Leu Ser Ser
Gln Ser Ile Ser
Gln Ser Leu Ser
Gln Ser Ser Ile
Gln Ser Ser Leu
Gln Ser Thr Val
Gln Ser Val Thr
Gln Thr Ser Val
Gln Thr Val Ser
Gln Val Ser Thr
Gln Val Thr Ser
Arg Ala Ser Thr
Arg Ala Thr Ser
Arg Gly Thr Thr
Arg Ser Ala Thr
Arg Ser Thr Ala
Arg Thr Ala Ser
Arg Thr Gly Thr
Arg Thr Ser Ala
Arg Thr Thr Gly
Ser Ala Glu Lys
Ser Ala Lys Glu
Ser Ala Arg Thr
Ser Ala Thr Arg
Ser Glu Ala Lys
Ser Glu Lys Ala
Ser Ile Lys Ser
Ser Ile Asn Thr
Ser Ile Gln Ser
Ser Ile Ser Lys
Ser Ile Ser Gln
Ser Ile Thr Asn
Ser Lys Ala Glu
Ser Lys Glu Ala
Ser Lys Ile Ser
Ser Lys Leu Ser
Ser Lys Ser Ile
Ser Lys Ser Leu
Ser Lys Thr Val
Ser Lys Val Thr
Ser Leu Lys Ser
Ser Leu Asn Thr
Ser Leu Gln Ser
Ser Leu Ser Lys
Ser Leu Ser Gln
Ser Leu Thr Asn
Ser Asn Ile Thr
Ser Asn Leu Thr
Ser Asn Thr Ile
Ser Asn Thr Leu
Ser Gln Ile Ser
Ser Gln Leu Ser
Ser Gln Ser Ile
Ser Gln Ser Leu
Ser Gln Thr Val
Ser Gln Val Thr
Ser Arg Ala Thr
Ser Arg Thr Ala
Ser Ser Ile Lys
Ser Ser Ile Gln
Ser Ser Lys Ile
Ser Ser Lys Leu
Ser Ser Leu Lys
Ser Ser Leu Gln
Ser Ser Gln Ile
Ser Ser Gln Leu
Ser Thr Ala Arg
Ser Thr Ile Asn
Ser Thr Lys Val
Ser Thr Leu Asn
Ser Thr Asn Ile
Ser Thr Asn Leu
Ser Thr Gln Val
Ser Thr Arg Ala
Ser Thr Val Lys
Ser Thr Val Gln
Ser Val Lys Thr
Ser Val Gln Thr
Ser Val Thr Gln
Thr Ala Asp Lys
Thr Ala Arg Ser
Thr Ala Ser Arg
Thr Gly Arg Thr
Thr Gly Thr Arg
Thr Lys Ser Val
Thr Lys Val Ser
Thr Arg Ala Ser
Thr Arg Gly Thr
Thr Arg Ser Ala
Thr Arg Thr Gly
Thr Ser Ala Arg
Thr Ser Lys Val
Thr Ser Arg Ala
Thr Ser Val Lys
Thr Thr Gly Arg
Thr Thr Arg Gly
Thr Val Lys Ser
Thr Val Ser Lys
Val Gly Lys Met
Val Gly Met Lys
Val Lys Gly Met
Val Lys Met Gly
Val Lys Ser Thr
Val Lys Thr Ser
Val Met Gly Lys
Val Met Lys Gly
Val Ser Lys Thr
Val Ser Thr Lys
Val Thr Lys Ser
Val Thr Ser Lys
Hericenone B
Aplidic acid C
NA 28:11;O2
2-[[(9H-Fluoren-9-ylmethoxy)carbonyl]amino]-2-(4-penten-1-yl)-6-heptenoic acid
tert-butyl N-[(1S)-2-[(1S,3S,5S)-3-carbamoyl-2-azabicyclo[3.1.0]hexan-2-yl]-1-(3-hydroxy-1-adamantyl)-2-oxoethyl]carbamate
TERT-BUTYL 4-(2-NITRO-4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)PIPERAZINE-1-CARBOXYLATE
Ulipristal
G - Genito urinary system and sex hormones > G03 - Sex hormones and modulators of the genital system > G03X - Other sex hormones and modulators of the genital system > G03XB - Progesterone receptor modulators G - Genito urinary system and sex hormones > G03 - Sex hormones and modulators of the genital system > G03A - Hormonal contraceptives for systemic use > G03AD - Emergency contraceptives C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C1891 - Progesterone Antagonist
Ethanone, 1-[3-ethyl-4-(hydroxymethyl)phenyl]-,O-[[4-cyclohexyl-3-(trifluoromethyl)phenyl]methyl]oxime, (1E)-
1H-Indole-1-carboxamide, 6-fluoro-2,3-dihydro-3,3-dimethyl-2-oxo-N-((1-((tetrahydro-4-hydroxy-2H-pyran-4-yl)methyl)-4-piperidinyl)methyl)-
(R)-N-(4-(tert-Butyl)phenyl)-N-(2-(tert-butylamino)-2-oxo-1-(pyridin-3-yl)ethyl)furan-2-carboxamide
COVID info from PDB, Protein Data Bank Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
(S)-N-(4-(tert-Butyl)phenyl)-N-(2-(tert-butylamino)-2-oxo-1-(pyridin-3-yl)ethyl)furan-2-carboxamide
6-[[4-(1,3-benzodioxol-5-ylmethyl)-1-piperazinyl]methyl]-N2-(3-methylphenyl)-1,3,5-triazine-2,4-diamine
{1-[2-(1-Formyl-propyl)-3-methanesulfonylamino-pyrrolidine-1-carbonyl]-2-methyl-propyl}-carbamic acid tert-butyl ester
Ethyl 3-[7-(diaminomethyl)naphthalen-2-yl]-2-(4-pyrrolidin-3-yloxyphenyl)propanoate
(13S)-7-hydroxy-12,12-dimethyl-8-(3-methylbut-2-enyl)-10,19,21-triazahexacyclo[13.5.2.01,13.03,11.04,9.015,19]docosa-3(11),4(9),5,7-tetraene-20,22-dione
N-[2-(tert-butylamino)-2-oxo-1-(3-pyridinyl)ethyl]-N-(4-tert-butylphenyl)-1H-imidazole-5-carboxamide
3,4-Dimethoxybenzaldehyde [4-anilino-6-(1-piperidinyl)-1,3,5-triazin-2-yl]hydrazone
3-[(2E,4E,8S,10E,12Z)-4,8-dimethyltetradeca-2,4,10,12-tetraenoyl]-4-hydroxy-5-(4-hydroxyphenyl)-1,2-dihydropyridin-2-one
2-(dimethylamino)-1-[(8R,9R,10R)-10-(hydroxymethyl)-9-[4-[(E)-2-phenylethenyl]phenyl]-1,6-diazabicyclo[6.2.0]decan-6-yl]ethanone
2-(dimethylamino)-1-[(8S,9R,10S)-10-(hydroxymethyl)-9-[4-[(E)-2-phenylethenyl]phenyl]-1,6-diazabicyclo[6.2.0]decan-6-yl]ethanone
2-(dimethylamino)-1-[(8R,9S,10R)-10-(hydroxymethyl)-9-[4-[(E)-2-phenylethenyl]phenyl]-1,6-diazabicyclo[6.2.0]decan-6-yl]ethanone
N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(1-oxopropyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
N-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]oxane-4-carboxamide
N-[(5S,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-oxanecarboxamide
N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-oxanecarboxamide
N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-oxanecarboxamide
N-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-oxanecarboxamide
N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propanoyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(1-oxopropyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
N-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-oxanecarboxamide
N-[(4S,7S,8S)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(4S,7S,8R)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(5S,6R,9R)-8-acetyl-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(5R,6R,9S)-8-acetyl-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(5R,6S,9R)-8-acetyl-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
2-(dimethylamino)-1-[(8R,9S,10S)-10-(hydroxymethyl)-9-[4-[(E)-2-phenylethenyl]phenyl]-1,6-diazabicyclo[6.2.0]decan-6-yl]ethanone
(8R,9S,10R)-9-[4-[(3R)-3-hydroxybut-1-ynyl]phenyl]-10-(hydroxymethyl)-N-phenyl-1,6-diazabicyclo[6.2.0]decane-6-carboxamide
(8R,9R,10S)-9-[4-[(3R)-3-hydroxybut-1-ynyl]phenyl]-10-(hydroxymethyl)-N-phenyl-1,6-diazabicyclo[6.2.0]decane-6-carboxamide
(8S,9R,10R)-9-[4-[(3S)-3-hydroxybut-1-ynyl]phenyl]-10-(hydroxymethyl)-N-phenyl-1,6-diazabicyclo[6.2.0]decane-6-carboxamide
N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(1-oxopropyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(1-oxopropyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(1-oxopropyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(1-oxopropyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
N-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-oxanecarboxamide
N-[(4R,7R,8S)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(4R,7R,8R)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(4S,7R,8R)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(4R,7S,8S)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(4R,7S,8R)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(4S,7R,8S)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(5R,6R,9R)-8-acetyl-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(5S,6S,9S)-8-acetyl-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(5S,6S,9R)-8-acetyl-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(5S,6R,9S)-8-acetyl-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
2-(dimethylamino)-1-[(8S,9S,10R)-10-(hydroxymethyl)-9-[4-[(E)-2-phenylethenyl]phenyl]-1,6-diazabicyclo[6.2.0]decan-6-yl]ethanone
2-(dimethylamino)-1-[(8R,9R,10S)-10-(hydroxymethyl)-9-[4-[(E)-2-phenylethenyl]phenyl]-1,6-diazabicyclo[6.2.0]decan-6-yl]ethanone
2-(dimethylamino)-1-[(8S,9R,10R)-10-(hydroxymethyl)-9-[4-[(E)-2-phenylethenyl]phenyl]-1,6-diazabicyclo[6.2.0]decan-6-yl]ethanone
(8S,9R,10R)-9-[4-[(3R)-3-hydroxybut-1-ynyl]phenyl]-10-(hydroxymethyl)-N-phenyl-1,6-diazabicyclo[6.2.0]decane-6-carboxamide
(8R,9S,10S)-9-[4-[(3R)-3-hydroxybut-1-ynyl]phenyl]-10-(hydroxymethyl)-N-phenyl-1,6-diazabicyclo[6.2.0]decane-6-carboxamide
(8S,9R,10S)-9-[4-[(3R)-3-hydroxybut-1-ynyl]phenyl]-10-(hydroxymethyl)-N-phenyl-1,6-diazabicyclo[6.2.0]decane-6-carboxamide
(2S,3S,3aR,9bR)-N-(2,3-dihydro-1H-inden-2-yl)-1-ethyl-3-(hydroxymethyl)-6-oxo-7-[(E)-prop-1-enyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
(2R,3R,3aS,9bS)-N-(2,3-dihydro-1H-inden-2-yl)-1-ethyl-3-(hydroxymethyl)-6-oxo-7-[(E)-prop-1-enyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
(1S,9R,10R,11R)-11-(3,4-dihydro-1H-isoquinoline-2-carbonyl)-12-ethyl-10-(hydroxymethyl)-5-[(Z)-prop-1-enyl]-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-dien-6-one
(1R,9S,10S,11S)-11-(3,4-dihydro-1H-isoquinoline-2-carbonyl)-12-ethyl-10-(hydroxymethyl)-5-[(Z)-prop-1-enyl]-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-dien-6-one
3-[2-[2-benzyl-6-[(3R,4R)-3-hydroxy-4-methoxypyrrolidin-1-yl]pyridin-3-yl]ethynyl]-1-azabicyclo[2.2.2]octan-3-ol
2-aminoethyl [3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]-2-hydroxypropyl] hydrogen phosphate
N-Formyl-norleucyl-leucyl-phenylalanyl-methylester
Etrinabdione
Etrinabdione (EHP-101; VCE-004.8) is an orally active, specific PPARγ and CB2 receptor dual agonist. Etrinabdione inhibits prolyl-hydroxylases (PHDs) and activates the HIF pathway. Etrinabdione, a semi-synthetic multitarget cannabinoquinoid, has potent anti-inflammatory activity. Etrinabdione attenuates adipogenesis and prevents diet-induced obesity[1][2]. Etrinabdione (EHP-101; VCE-004.8) is an orally active, specific PPARγ and CB2 receptor dual agonist. Etrinabdione inhibits prolyl-hydroxylases (PHDs) and activates the HIF pathway. Etrinabdione, a semi-synthetic multitarget cannabinoquinoid, has potent anti-inflammatory activity. Etrinabdione attenuates adipogenesis and prevents diet-induced obesity[1][2].